Melissa Calegaro Nassif
Universidade Federal do Rio Grande do Sul
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Melissa Calegaro Nassif.
Neurobiology of Disease | 2006
Lauren Lúcia Zamin; Patrícia Dillenburg-Pilla; Ricardo Argenta-Comiran; Ana Paula Horn; Fabrício Simão; Melissa Calegaro Nassif; Daniéli Gerhardt; Rudimar Luiz Frozza; Christianne Gazzana Salbego
Here we investigated the neuroprotective effect of resveratrol in an in vitro model of ischemia. We used organotypic hippocampal cultures exposed to oxygen-glucose deprivation (OGD). In OGD-vehicle exposed cultures, about 46% of the hippocampus was labeled with PI, indicating a robust percentage of cell death. When cultures were treated with resveratrol 10, 25 and 50 microM, the cell death was reduced to 22, 20 and 13% respectively. To elucidate a possible mechanism by which resveratrol exerts its neuroprotective effect, we investigated the phosphoinositide3-kinase (PI3-k) pathway using LY294002 (5 microM) and mitogen-activated protein kinase (MAPK) using PD98059 (20 microM). The resveratrol (50 microM) neuroprotection was prevented by LY294002 but was not by PD98059. Immunoblotting revealed that resveratrol 50 microM induced the phosphorylation/activation of Akt and extracellular signal-regulated kinase-1 and -2 (ERK1/2) and the phosphorylation/inactivation of glycogen synthase kinase-3beta (GSK-3beta). Our results suggest that PI3-k/Akt pathway are involved in the neuroprotective effect of resveratrol.
Neurochemical Research | 2005
Helena Iturvides Cimarosti; Lauren Lúcia Zamin; Rudimar Luiz Frozza; Melissa Calegaro Nassif; Ana Paula Horn; Alexandre Altino Tavares; Carlos Alexandre Netto; Christianne Gazzana Salbego
Here we investigated the neuroprotective effect of 17β-estradiol in an in vitro model of ischemia. We used organotypic hippocampal slice cultures, acute or chronically treated with 17β-estradiol (10 nM), and exposed to oxygen and glucose deprivation (OGD). Cellular death was quantified by measuring uptake of propidium iodide (PI), a marker of dead cells. In OGD exposed cultures, treated only with vehicle, about 70% of the CA1 area of hippocampus was labeled with PI, indicating a great percentage of cellular death. When cultures were treated with 17β-estradiol (acute or chronically), this cellular death was reduced to 15%. This effect was prevented by LY294002 but was not by PD98059. Immunoblotting revealed that both, chronic and acute, treatments with 17β-estradiol induced the phosphorylation/activation of Akt and the phosphorylation/inactivation of GSK-3β. Our results show a clear neuroprotective effect of 17β-estradiol and suggest that this effect could involve PI3-K pathway.
Neurotoxicology | 2008
Eduardo Luis Konrath; Katiane Santin; Melissa Calegaro Nassif; Alexandra Latini; Amelia Teresinha Henriques; Christianne Gazzana Salbego
Boldine is one of the most potent natural antioxidants and displays some important pharmacological activities, such as cytoprotective and anti-inflammatory activities, which may arise from its free radical scavenging properties. Given that the pathogenesis of brain ischemia/reperfusion has been associated with an excessive generation of oxygen free radicals, the aim of this study was to evaluate the neuroproperties of boldine using hippocampal slices from Wistar rats exposed to oxygen and glucose deprivation (OGD), followed by reoxygenation, to mimic an ischemic condition. The OGD ischemic condition significantly impaired cellular viability, increased lactate dehydrogenase (LDH) leakage and increased free radical generation. In non-OGD slices, incubation with 100microM boldine significantly increased LDH released into incubation media and decreased mitochondrial activity, suggesting an increase of tissue damage caused by boldine. However, slices incubated with 10microM boldine during and after OGD exposure had significantly increased cellular viability with no effect on cell damage. Total reactive antioxidant potential (TRAP) levels measured for this alkaloid showed an antioxidant potential three times higher than Trolox, which acts as a peroxyl radical scavenger. Moreover, boldine prevented the increase in lipoperoxidation levels induced by ischemia, but higher concentrations potentiated this parameter. These results confirm the potent antioxidant properties of this alkaloid, and add evidence to support the need for further investigations in order to confirm the potential pro-oxidant effects of boldine at higher doses.
Neurochemical Research | 2005
Helena Iturvides Cimarosti; Ionara Rodrigues Siqueira; Lauren Lúcia Zamin; Melissa Calegaro Nassif; Rodrigo de Souza Balk; Rudimar Luiz Frozza; Carla Dalmaz; Carlos Alexandre Netto; Christianne Gazzana Salbego
ABSTRACTHere we investigated the effects of estradiol replacement in ovariectomized female rats using hippocampal slices exposed to oxygen-glucose deprivation (OGD). OGD induced lactate dehydrogenase (LDH) release to the incubation medium, what was assumed as a parameter of cellular death. In the estradiol-treated group the LDH release was markedly decreased by 23% as compared to the vehicle-treated group. In attempt to study a possible mechanism by which estradiol acts, we investigated some parameters of oxidative stress. In both vehicle-treated and estradiol-treated groups, OGD significantly increased the free radical production by 34% and 16%, respectively, although no significant differences on total antioxidant capacity were observed. Interestingly, estradiol replacement prevented the significant reduction in tryptophan and tyrosine contents caused by OGD observed in vehicle-treated animals. Our results show that estradiol replacement in ovariectomized female rats decreases cellular susceptibility to an ischemic-like injury and suggest a role for the hormone on protein damage prevention.
Neurological Research | 2009
Fabrício Simão; Lauren Lúcia Zamin; Rudimar Luiz Frozza; Melissa Calegaro Nassif; Ana Paula Horn; Christianne Gazzana Salbego
Abstract Objective: Brain ischemia results in cellular degeneration and loss of brain function. Oxcarbazepine (OXC), one of the newer antiepileptic drugs, has been demonstrating its efficacy on wide spectrum neurological disorders. In this paper, we investigated the neuroprotective profile of OXC in an in vitro model of ischemia, which consists in the exposure of organotypic hippocampal slice cultures to oxygen and glucose deprivation. Methods: OXC (30 μM) was added to the medium before and/or during and/or after the oxygen and glucose deprivation induction. Cell death was quantified by propidium iodide uptake measurement. Immunoblotting was used to detect the phosphorylation of Akt. Results: Our results showed a decrease in propidium iodide incorporation when OXC was added before oxygen and glucose deprivation, suggesting a neuroprotective effect. This effect was prevented when cultures were previously treated with LY294002, an inhibitor of phosphoinositide-3-kinase (PI3K) pathway. We also analysed the effect of OXC on Akt phosphorylation. Immunoblotting revealed that OXC did not induce any change in phosphorylation/activation of Akt. Discussion: Our results reinforce the neuroprotective effect of OXC and add some evidence that its mechanism may involve the PI3K pathway, suggesting that such effect could be upstream Akt. This indicates that with respect to OXC neuroprotective, Akt may not play a crucial role in determining cell survival.
Neurochemistry International | 2007
Melissa Calegaro Nassif; Juliana Bender Hoppe; Katiane Santin; Rudimar Luiz Frozza; Lauren Lúcia Zamin; Fabrício Simão; Ana Paula Horn; Christianne Gazzana Salbego
Neurochemical Research | 2006
Helena Iturvides Cimarosti; Ross D. O'Shea; Nicole M. Jones; Ana Paula Horn; Fabrício Simão; Lauren Lúcia Zamin; Melissa Calegaro Nassif; Rudimar Luiz Frozza; Carlos Alexandre Netto; Philip M. Beart; Christianne Gazzana Salbego
Neurochemical Research | 2011
Ana Paula S. de Vasconcellos-Bittencourt; Deusa Vendite; Melissa Calegaro Nassif; Leonardo Machado Crema; Rudimar Luiz Frozza; Ana Paula Thomazi; Fabiane Nieto; Susana Tchernin Wofchuk; Christianne Gazzana Salbego; Elizabete Rocha da Rocha; Carla Dalmaz
Infarma - Ciências Farmacêuticas | 2013
Melissa Calegaro Nassif; Helena Iturvides Cimarosti; Lauren Lúcia Zamin; Christianne Gazzana Salbego
Infarma - Ciências Farmacêuticas | 2013
Melissa Calegaro Nassif; Juliana Bender Hoppe; Christianne Gazzana Salbego